NEW YORK (GenomeWeb) – Digital PCR can better detect hints of residual disease in chronic myeloid leukemia patients than other PCR-based approaches, according to a team of UK researchers.

With tyrosine kinase inhibitor (TKI) treatment, CML can be rendered nearly undetectable in patients. But while some patients remain disease-free after treatment is halted, others can relapse. This, the researchers said, highlights the need for ways to detect even low levels of disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.